Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
41,289,826
-
Share change
-
-1,745,349
-
Total reported value
-
$1,012,514,673
-
Put/Call ratio
-
640%
-
Price per share
-
$24.51
-
Number of holders
-
173
-
Value change
-
-$40,858,823
-
Number of buys
-
81
-
Number of sells
-
82
Institutional Holders of AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) as of Q3 2016
As of 30 Sep 2016,
AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,289,826 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, FMR LLC, Palo Alto Investors, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, D. E. Shaw & Co., Inc., STELLIAM INVESTMENT MANAGEMENT, LP, and GLENMEDE TRUST CO NA.
This page lists
173
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.